Evidence map›Paper›PMID 26189939›Full record

ArticleInfection2016

Francisella tularensis aortitis.

M Briere, A Kaladji, F Douane, J P Breux, P Touroult-Jupin, S Boisset, S Edouard, C Biron, D Boutoille

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Infection, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Frontiers in cellular and infection microbiology · 2020
    Review
  6. Isolation ofFrontiers in microbiology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

M BriereDepartment of Infectious Diseases, CHU Nantes, Nantes, France. magalibriere1979@yahoo.fr.
A KaladjiDepartment of Vascular Surgery, CHU Nantes, Nantes, France.
F DouaneDepartment of Radiology, CHU Nantes, Nantes, France.
J P BreuxDepartment of Medicine and Infectious Diseases, CH Cholet, Cholet, France.
P Touroult-JupinDepartment of Microbiology, CH Cholet, Cholet, France.
S BoissetNational Reference Center for Francisella, CHU Grenoble, Grenoble, France.
S EdouardNational Reference Center for Rickettsiosis and Francisella tularensis, Institut Hospital-Universitaire Méditerranée-Infection, Aix-Marseille Université, Marseille, France.
C BironDepartment of Infectious Diseases, CHU Nantes, Nantes, France.
D BoutoilleDepartment of Infectious Diseases, CHU Nantes, Nantes, France.
Centre Hospitalier de Lens · FRCentre Hospitalier Universitaire de Nantes · FRAix-Marseille Université · FRCentre Hospitalier Universitaire de Grenoble · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Francisella tularensis, the agent of tularemia, is a Gram-negative coccobacillus primarily pathogen for animals and occasionally for humans. The clinical manifestations of tularemia include pneumonia, ulceroglandular, oropharyngeal, or typhoidal disease. Rare manifestations are also described, but to our knowledge, we describe here the first case of F. tularensis aortitis in a human. Diagnosis was confirmed by the presence of F. tularensis in blood culture, by the presence of F. tularensis DNA in the aortic biopsy and by specific IgG and IgM responses against the bacteria. The outcome was favorable after surgery and specific antimicrobial therapy.

Indexed as

Aged, 80 and overAnimalsAnti-Bacterial AgentsAntibodies, BacterialAortaAortitisBiopsyBloodDebridementDNA, BacterialFrancisella tularensisHumansImmunoglobulin GImmunoglobulin MMaleTreatment OutcomeAnti-Bacterial AgentsAntibodies, BacterialDNA, BacterialImmunoglobulin GImmunoglobulin MAortitisAtherosclerosisBacteremiaInfrequent presentationTularemia

Identifiers

PMID26189939
OpenAlexW1007831530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.